J Pharmacol Exp Ther 2000, 294:126–133 PubMed 12 Pastor-Anglada

J Pharmacol Exp Ther 2000, 294:126–133.PubMed 12. Pastor-Anglada M, Errasti-Murugarren

LY294002 chemical structure E, Aymerich I, Casado FJ: Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling. J Physiol Biochem 2007, 63:97–110.PubMedCrossRef 13. Agteresch HJ, Dagnelie PC, Rietveld T, van den Berg JW, Danser AH, Wilson JH: Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 2000, 56:49–55.PubMedCrossRef 14. Huyghebaert N, Vermeire A, Remon JP: In vitro evaluation of coating polymers for enteric coating and human ileal targeting. Int J Pharm 2005, 298:26–37.PubMedCrossRef 15. Coolen EJCM, Arts ICW, Swennen ELR, Bast A, Cohen Stuart MA, Dagnelie PC: Simultaneous determination of adenosine triphosphate and its metabolites in human whole blood by RP-HPLC and UV-detection. J Chromatogr B 2008, 864:43–51.CrossRef 16. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva

TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, et al.: The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997, 99:1351–1360.PubMedCrossRef 17. Trapp GA: Matrix modifiers in graphite furnace atomic absorption analysis of trace lithium in biological fluids. Anal Biochem 1985, 148:127–132.PubMedCrossRef 18. Haskell CM, Wong SB202190 research buy M, Williams A, Lee LY: Phase I trial of extracellular adenosine 5′-triphosphate in patients with advanced cancer. Med Pediatr Oncol 1996, 27:165–173.PubMedCrossRef 19. Agteresch HJ, Rietveld T, Kerkhofs LG, van den Berg JW, Wilson JH, Dagnelie PC: Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trial. J Clin Oncol 2002, 20:371–378.PubMedCrossRef 20. Yegutkin GG: Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling

cascade. Biochim Biophys Acta 2008, 1783:673–694.PubMedCrossRef mafosfamide 21. Strohmeier GR, Lencer WI, Patapoff TW, Thompson LF, Carlson SL, Moe SJ, Carnes DK, Mrsny RJ, Madara JL: Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest 1997, 99:2588–2601.PubMedCrossRef 22. Mohamedali KA, Guicherit OM, Kellems RE, Rudolph FB: The CHIR98014 highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. J Biol Chem 1993, 268:23728–23733.PubMed 23. Ngo LY, Patil SD, Unadkat JD: Ontogenic and longitudinal activity of Na(+)-nucleoside transporters in the human intestine. Am J Physiol Gastrointest Liver Physiol 2001, 280:G475-G481.PubMed 24. Griffith DA, Jarvis SM: Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996, 1286:153–181.PubMedCrossRef 25. Fox IH: Metabolic basis for disorders of purine nucleotide degradation. Metabolism 1981, 30:616–634.PubMedCrossRef 26.

Comments are closed.